Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

10826	Companies
234866	Keywords
163735	Articles
125714	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 06/23/2026 at 15:00, 1 month 19 days ago

Jaguar Health Completes Submission of New Animal Drug Application for Full FDA Approval of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Jaguar submits NADA for Canalevia-CA1 to FDA for CID in dogs, reporting positive results in study. Crofelemer effectively treats chemotherapy-induced diarrhea

Veterinary Medicine Jaguar Health Canalevia-CA1 Chemotherapy-induced Diarrhea NADA Submission
BRIEF

published on 06/22/2026 at 15:05, 1 month 20 days ago

Jaguar Health Explores Strategic Alternatives for Intestinal Failure Program

Crofelemer Biotechnology Strategic Alternatives Jaguar Health Intestinal Failure
BRIEF

published on 06/22/2026 at 15:05, 1 month 20 days ago

Jaguar Health explore des alternatives stratégiques pour son programme de prise en charge de l'insuffisance intestinale

Crofelemer Biotechnologie Jaguar Health Alternatives Stratégiques Insuffisance Intestinale
PRESS RELEASE

published on 06/22/2026 at 15:00, 1 month 20 days ago

Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
Jaguar Health, Inc. to explore strategic alternatives maximizing stockholder value. Updates on crofelemer program for rare intestinal failure diseases by CEO Lisa Conte at Life Sciences Virtual Investor Forum on June 24, 2026

Crofelemer Strategic Alternatives Jaguar Health Lisa Conte Intestinal Failure Diseases
BRIEF

published on 06/18/2026 at 15:05, 1 month 24 days ago

Magdalena Biosciences dévoile des résultats précliniques prometteurs sur l'extrait de coca

Magdalena Biosciences Étude Préclinique Gestion De La Perte De Poids Extrait De Feuille De Coca Conseils Botaniques
BRIEF

published on 06/18/2026 at 15:05, 1 month 24 days ago

Magdalena Biosciences Unveils Promising Preclinical Study Results on Coca Extract

Magdalena Biosciences Preclinical Study Weight Loss Management Coca Leaf Extract Botanical Guidance
PRESS RELEASE

published on 06/18/2026 at 15:00, 1 month 24 days ago

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Announces Positive Results of Preclinical Study of Coca for Weight Gain Prevention
Magdalena's drug candidate, a coca leaf extract, shows promise for post-GLP-1 weight loss management. Preclinical study results suggest potential as weight maintenance therapy

Preclinical Study Magdalena GLP-1 Therapy Weight Loss Management Coca Leaf Extract
BRIEF

published on 06/12/2026 at 15:05, 2 months ago

Jaguar Health to Present at Life Sciences Virtual Investor Forum

Crofelemer Jaguar Health Intestinal Failure Life Sciences Forum Pediatric Studies
BRIEF

published on 06/12/2026 at 15:05, 2 months ago

Jaguar Health présentera ses services lors du Forum virtuel des investisseurs en sciences de la vie

Crofelemer Jaguar Health Insuffisance Intestinale Forum Des Sciences De La Vie Études Pédiatriques
PRESS RELEASE

published on 06/12/2026 at 15:00, 2 months ago

Jaguar Health Presenting June 24, 2026 at the Life Sciences Virtual Investor Forum to Provide Updates on Company's Crofelemer Development Program for Rare Intestinal Failure Diseases
Jaguar Health, Inc. announces virtual presentation by CEO Lisa Conte at Life Sciences Virtual Investor Forum on June 24, 2026. Crofelemer presentations at ESPGHAN Meeting

Virtual Presentation Jaguar Health Lisa Conte Life Sciences Forum ESPGHAN Meeting

Accesswire

Published on 08/12/2026 at 15:42, 2 hours 52 minutes ago

Critical Elements 10,000-Meter Summer Drill Program at Rose West Resumes with Positive Results
Published on 08/12/2026 at 15:42, 2 hours 52 minutes ago

Critical Elements redémarre son programme de forage estival de 10 000 mètres à Rose Ouest avec des résultats positifs
Published on 08/12/2026 at 15:00, 3 hours 34 minutes ago

Karbon-X and Core Energy Sign Letter of Intent to Explore Commercial EV Charging Infrastructure in South America
Published on 08/12/2026 at 14:45, 3 hours 49 minutes ago

Lobe Sciences Ltd. Announces Non-Brokered Private Placement
Published on 08/12/2026 at 14:30, 4 hours 4 minutes ago

Recent Corporate Events Recap

View all ACCESSWIRE

EQS Group

Published on 08/12/2026 at 18:29, 5 minutes ago

Designated Persons Notifications
Published on 08/12/2026 at 18:29, 5 minutes ago

Designated Persons Notifications
Published on 08/12/2026 at 18:17, 17 minutes ago

EQS-Adhoc: Gateway Real Estate AG resolves segment change from the regulated market (Prime Standard) to the Scale segment of the open market (Freiverkehr) on the Frankfurt Stock Exchange
Published on 08/12/2026 at 18:15, 19 minutes ago

Shelly Group Delivers Strong Revenue and Earnings Growth in the First Six Months of 2026
Published on 08/12/2026 at 18:00, 34 minutes ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.07.26

Les Echos

Published on 08/11/2026 at 17:45, 1 day ago

DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day ago

Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 2 days ago

Weekly share buyback

View all LES ECHOS COMFI WIRE